|
Market Closed -
London S.E.
20:35:03 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.9750 GBX | 0.00% |
|
-11.36% | +11.43% |
| 10-12 | Tialis wins "significant" utilities contract | AN |
| 10-12 | Genedrive PLC Notes NIHR Case Study On Development, Clinical Validation And Adoption Of Genedrive MT-RNR1 ID Kit | CI |
Company Valuation: genedrive plc
Data adjusted to current consolidation scope
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 53.01 | 35.61 | 16.19 | 17.33 | 8.962 | 8.749 |
| Change | - | -32.82% | -54.52% | 7.04% | -48.3% | -2.38% |
| Enterprise Value (EV) 1 | 56.39 | 33.15 | 11.62 | 14.97 | 3.793 | 7.567 |
| Change | - | -41.21% | -64.95% | 28.85% | -74.67% | 99.5% |
| P/E | -1.85x | -46.9x | -3.18x | -3.18x | -0.35x | -1.51x |
| PBR | -15.9x | 9.92x | 2.89x | 8.49x | 1.67x | 6.08x |
| PEG | - | 0.5x | -0x | 19.25x | 0x | 0x |
| Capitalization / Revenue | 50.1x | 51.8x | 330x | 315x | 17.9x | 9.17x |
| EV / Revenue | 53.2x | 48.3x | 237x | 272x | 7.57x | 7.93x |
| EV / EBITDA | -10.1x | -6.11x | -2.09x | -2.9x | -0.72x | -1.42x |
| EV / EBIT | -10x | -6.05x | -2.07x | -2.87x | -0.71x | -1.41x |
| EV / FCF | -17.2x | -7.61x | -3.48x | -10.4x | -1x | -2.26x |
| FCF Yield | -5.83% | -13.1% | -28.7% | -9.64% | -99.6% | -44.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.55 | -0.012 | -0.0551 | -0.055 | -0.047 | -0.009293 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.059 | 0.687 | 0.049 | 0.055 | 0.501 | 0.954 |
| EBITDA 1 | -5.583 | -5.422 | -5.552 | -5.163 | -5.258 | -5.33 |
| EBIT 1 | -5.64 | -5.482 | -5.615 | -5.224 | -5.312 | -5.38 |
| Net income 1 | -19.42 | -0.691 | -4.675 | -5.15 | -7.075 | -5.231 |
| Net Debt 1 | 3.381 | -2.455 | -4.573 | -2.36 | -5.169 | -1.182 |
| Reference price 2 | 1.020000 | 0.562500 | 0.175000 | 0.175000 | 0.016500 | 0.014000 |
| Nbr of stocks (in thousands) | 51,967 | 63,302 | 92,535 | 99,050 | 543,141 | 624,895 |
| Announcement Date | 27/11/20 | 16/11/21 | 05/12/22 | 06/12/23 | 05/12/24 | 08/12/25 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 20.97M | |
| 35.69x | 6.07x | 23.2x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 39.98x | 7.18x | 21.15x | 0.43% | 88.35B | |
| Weighted average by Cap. | 39.12x | 7.39x | 22.11x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EHP Stock
- Valuation genedrive plc
Select your edition
All financial news and data tailored to specific country editions
